11:04 GMT +320 July 2019
Listen Live
    Russian Healthcare Minister Veronika Skvortsova demostrates Anti-Ebola fever vaccine packages at Gamalei Research Institute of Epidemiology and Microbiology

    Russian Vaccine Against Ebola Waiting for Second Phase of Clinical Tests

    © Sputnik / Ramil Sitdikov
    Russia
    Get short URL
    Ebola Outbreak in West Africa (248)
    0 84

    A vaccine against Ebola disease, developed by Russia's Vector Research Center of Virology and Biotechnology, is being approved by the Russian Ministry of Heathcare and waiting for the second phase of trials, the acting general director of the center said Thursday.

    NOVOSIBIRSK (Sputnik) — In May, Anna Popova, the head of Russia's consumer rights watchdog Rospotrebnadzor, said that the Russian vaccine against Ebola disease had passed the first phase of clinical tests on 60 volunteers and had shown its effectiveness.

    "The vaccine has passed the first phase of clinical trials, it is now being approved by the Russian Ministry of Healthcare. We are waiting for the second phase of [trials]," Valery Mikheyev told reporters on the sidelines of the Technoprom 2016 international forum in the Russian city of Novosibirsk.

    The most recent Ebola outbreak started in December 2013 in Guinea and later spread to Liberia and Sierra Leone. The virus has claimed the lives of over 11,000 people, according to WHO estimates.

    A week ago, the WHO declared the end to the Ebola outbreak in Guinea.

    Topic:
    Ebola Outbreak in West Africa (248)

    Related:

    G7 Points to Need for WHO Reforms, Citing Lessons Learned From Ebola
    Africa Appreciates Russia's Help in Fight Against Ebola
    Is Ebola Back? Disease Kills Woman in Liberia
    Tags:
    vaccine, virus, outbreak, ebola, Russia
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik